As the coronavirus pandemic has been on the upswing in the United States and Europe, the race has begun among the pharma companies to apply to regulators for emergency use of their COVID-19 vaccine candidates.
American biotechnology company Moderna Inc. has announced that it would ask US and European regulators today to allow emergency use of its COVID-19 vaccine. They further say their study results have confirmed strong protection from the shots.
Moderna suggests the vaccine is more than 94% effective.
US hospitals has been witnessing a surge in the coronavirus positive cases and also fatalities. On an average, US has been seeing 160,000 new cases per day and more than 1,400 deaths daily.
Moderna, Pfizer and BioNTech are seeking seeking to begin vaccinations in the US in December.
ALSO READFPJ Explains: Front-runner COVID-19 vaccines developed by Pfizer, Moderna, AstraZeneca-Oxford &...
(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)